Resolutions from Extraordinary General Meeting of Elos Medtech AB (publ) 2021
Elos Medtech held its Extraordinary General Meeting (”EGM”) on 13 August 2021. Due to the ongoing Covid-19 pandemic, the EGM was carried out through postal voting only, without any physical attendance. The EGM took inter alia the following resolutions:
Determination of the number of members of the Board
The EGM resolved, in accordance with the proposal from the majority shareholder in Elos Medtech AB, TA Associates, through EM Intressenter AB, that for the period of until the end of the next Annual General Meeting, the number of ordinary members of the Board of Directors shall be five (formerly six).
Determination of the fees to be paid to the members of the Board
The EGM resolved, in accordance with the proposal from EM Intressenter AB, that the remuneration to the board of directors and for committee work until the end of the next Annual General Meeting shall be allocated pursuant to the same principles as resolved upon by the Annual General Meeting 2021, provided that no remuneration shall be allocated to board members that are not independent in relation to EM Intressenter AB and TA Associates.
Election and dismissal of Board members
The EGM resolved, in accordance with proposal from EM Intressenter AB, which in advanced had been shared with the chairman of the company’s nomination committee, that the EGM resolves to elect Birker Bahnsen, Lovisa Lander and Alexander Cicetti, for the period until the end of the next Annual General Meeting, as new Board members of Elos Medtech AB and that directors Anders Birgersson, Hanna Ernestam Wilkman, Claes Hansson and Jeppe Magnusson are dismissed. Such resolution results in that Yvonne Mårtensson and Jon Risfelt remain as board members and that Yvonne Mårtensson remain Chairman of the Board until the end of the next Annual General Meeting.
Minutes from the EGM together with complete decisions will be provided at the company’s webpage, www.elosmedtech.com.
For more information, please contact:
Jan Wahlström, CEO and President, 070 212 18 89, [email protected]
Ewa Linsäter, CFO, 076 633 32 33, [email protected]
For more information about the Group Elos Medtech, please see www.elosmedtech.com